1. Nephritis and nephrosis

Néphrite et néphrose

2. Nephritis, nephritic syndrome and nephrosis

Néphrite, syndrome néphritique et néphrose

3. Nephritis, nephrotic syndrome, and nephrosis 10.

Néphrite, syndrome néphrotique (ou néphrose) 10.

4. Nephritis, nephrotic syndrome and nephrosis (kidney disease)

Néphrite, syndrome néphrotique et néphropathie (maladie du rein)

5. Kidney calculus, urine abnormality, albuminuria, hypercalcinuria, nephritis, hyperuricemia

troubles articulaires Calculs rénaux, urines anormales, albuminurie, hypercalcinurie, néphrites, hyperuricémie

6. Sub-acute or chronic nephritis or nephrosis Renal failure, hypertension

Néphrite ou néphropathie chronique ou subaiguë Insuffisance rénale, hypertension

7. g Until # referred to as nephritis, nephritic syndrome and nephrosis

g Jusqu'en # on parlait de “néphrite, syndrome néphrotique et néphrose”

8. Until 1997 referred to as nephritis, nephritic syndrome and nephrosis.

Jusqu’en 1997, on parlait de “néphrite, syndrome néphrotique et néphrose”.

9. Enteritis, hepatitis, interstitial nephritis, and myositis, all of which began as acute reactions and developed into chronic lesions, were observed histologically.

On a observé du point de vue histologique des cas d'entérite, d'hépatite, de néphrite interstitielle et de myosite qui ont tous commencé comme des réactions aiguës pour devenir des lésions chroniques.

10. Clinical manifestations may include one or more of the following: fever, rash or severe dermatologic reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome); vasculitis, arthralgia, myalgia, serum sickness; allergic pneumonitis, interstitial nephritis; acute renal insufficiency or failure; hepatitis, jaundice, acute hepatic necrosis or failure; anemia, including hemolytic and aplastic; thrombocytopenia, including thrombotic thrombocytopenic purpura; leukopenia; agranulocytosis; pancytopenia; and/or other hematologic abnormalities.

Les manifestations cliniques peuvent inclure au moins l’un des symptômes suivants : fièvre, rash ou réactions dermatologiques graves (p. ex. nécrolyse épidermique toxique, syndrome de StevensJohnson), vasculite, arthralgie, myalgie, maladie sérique, pneumonite allergique, néphrite interstitielle, insuffisance rénale aiguë ou insuffisance rénale, hépatite, ictère, nécrose hépatique aiguë ou insuffisance hépatique aiguë, anémie (incluant l’anémie hémolytique et aplasique), thrombocytopénie (incluant le purpura thrombocytopénique thrombotique), leucopénie, agranulocytose, pancytopénie ou autres anomalies hématologiques.

11. 3¿ is aryl which may have suitable substituent(s), and A is lower alkylene, or a pharmaceutically acceptable salt thereof, for the treatment of various diseases selected from the group consisting of cardiac hypertrophy, nephropacy such as nephritis or renal failure, arteriosclerosis, obliterans, obstructive thrombus, arterial embolus, Bürger-Grütz syndrome, acrocyanosis, chilblain, frostbite, prolactin-producing ovulation disorder, prolactin-producing pituitary tumor, puerperal galactoschesia, galactorrhea, distal hypertrophy, pituitary gigantism, mental illness, cerebrovascular diseases, tachycardia accompanied by sympathetic hypertonia, hyperaldosteronism, and diabetic complication.

3¿ représente aryle ou éventuellement son ou ses substituants appropriés, et A représente alkylène inférieur.